BioSpace News Archive

Press Releases

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

July 31, 2025
·
3 min read
Press Releases

Teva’s Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components

July 31, 2025
·
56 min read
Press Releases

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

July 31, 2025
·
19 min read
Press Releases

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

July 31, 2025
·
5 min read
Press Releases

Immunitas Therapeutics Presents Preclinical Data on IMT-380, a First-in-Class Anti-CD161 Antibody, at FASEB Science Research Conference on Autoimmunity

July 31, 2025
·
4 min read
Press Releases

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study

July 31, 2025
·
6 min read
Press Releases

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025

July 31, 2025
·
1 min read
Press Releases

Vivace Therapeutics Announces Receipt of Orphan Drug Designation for VT3989 for Treatment of Mesothelioma

July 31, 2025
·
3 min read
Press Releases

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

July 31, 2025
·
1 min read
Press Releases

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

July 31, 2025
·
3 min read